S

Second Genome Inc.

11 employees

Second Genome offers a pipeline of microbiome modulators that impact infection, immunity and metabolic diseases.

Basic info

Industry

biotechnology research

Sectors

Medicine
Biotechnology
Health Diagnostics
Innovation
Medical
Drug Development
Drug Discovery
Microbiome

Date founded

2009

Funding rounds raised

Total raised

$51M

from 9 investors over 9 rounds

S

Second Genome Inc. raised $51M on April 13, 2016

Investors: Seraph Group, S.R. One Ltd, Lifeforce Capital, Morgenthaler, Digitalis Ventures and Mayo Clinic, Center for Innovation

S

Second Genome Inc. raised $6.5M on June 5, 2013

Investors: Wavepoint Ventures, LLC, Advanced Technology Ventures and Morgenthaler

FAQ